ReviewInsights into imaging2018
Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review.
Review in Insights into imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- The impact of mammographic breast density on locoregional recurrence in breast cancer: a systematic review and meta-analysis.Breast cancer research and treatment · 2025Pooled it
- Oncological surgery follow-up and quality of life: meta-analysis.The British journal of surgery · 2023Pooled it
- Impact of loving-kindness meditation intervention vs. music intervention during biopsy on adherence to recommended breast cancer screening.Breast cancer research and treatment · 2025Trial
- Artificial intelligence-assisted triage of screening mammograms following breast-conserving therapy: a comparative simulation study.La Radiologia medica · 2026Article
- Correspondence on: "Difficulty diagnosing breast cancer recurrence in the context of a radio-frequency-identification device-containing breast implant".JPRAS open · 2026Article
- External validation of a data-driven algorithm to identify breast cancer recurrences from administrative healthcare data.Breast (Edinburgh, Scotland) · 2026Article
- Article
- ESR Essentials: post-treatment breast cancer surveillance from mammography to a more personalised approach-practice recommendations by the European Society of Breast Imaging.European radiology · 2026Review
- Evaluating double-reading mammography for long-term surveillance in breast cancer survivors: a retrospective exploratory analysis from a single center.La Radiologia medica · 2026Article
- Impact of Digital Breast Tomosynthesis on Extra Views and Concomitant Ultrasound Examinations in One Year Post Breast-Conserving Surgery Patients.Journal of medical radiation sciences · 2025Article
- Breast cancer recurrence in relation to mode of detection: implications on personalized surveillance.Breast cancer research and treatment · 2025Article
- MR-contrast enhanced mammography (CEM) for follow-up of breast cancer patients: a "pros and cons" debate.European radiology · 2024Article
- Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk.Breast cancer research and treatment · 2024Article
- The Usefulness of Magnetic Resonance Imaging (MRI) for the Detection of Local Recurrence after Mastectomy with Reconstructive Surgery in Breast Cancer Patients.Diagnostics (Basel, Switzerland) · 2022Article
- Analysis of Artifacts on MRI from Electronic Identification Enablement in Silicone Gel Implants.Plastic and reconstructive surgery. Global open · 2022Article
- Article
- Fat necrosis: A consultant's conundrum.Frontiers in oncology · 2022Review
- Importance of long-term monitoring of patients with breast reconstructions: a case of 10-year cancer recurrence.Case reports in plastic surgery & hand surgery · 2022Article
- Contemporary Outcomes After Multimodality Therapy in Patients With Breast Cancer Presenting With Ipsilateral Supraclavicular Node Involvement.International journal of radiation oncology, biology, physics · 2022Article
- Participation in breast cancer screening among breast cancer survivors -A nationwide register-based cohort study.Breast (Edinburgh, Scotland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe article summarises the available guidelines on breast imaging surveillance after curative treatment for locoregional breast cancer.
methodsA systematic review of practice guidelines published from 1 January 2007 to 1 January 2017 was performed according to PRISMA methodology. The search was conducted for the EMBASE, MEDLINE, Cochrane and Centre for Reviews and Dissemination databases. On 8 July 2018, all included guidelines were updated to the most recent version.
resultsTwenty-one guidelines originating from 18 publishing bodies matched criteria. Publishing bodies consisted of seven governmental institutions, nine medical societies and two mixed collaborations. Publishing boards consisted of six radiological, four oncological, and 11 multidisciplinary teams. Annual bilateral mammography surveillance after breast-conserving therapy was recommended by 17/18 (94.4%) publishing bodies. Annual contralateral mammography surveillance after mastectomy was recommended by 13/18 (72.2%) publishing bodies. Routine use of digital breast tomosynthesis was recommended by 1/18 (5.6%) publishing bodies. Routine breast ultrasound surveillance was recommended by 2/18 (11.1%), deemed optional by 4/18 (22.2%) and not supported by 8/18 (44.4%) publishing bodies. Routine breast magnetic resonance imaging (MRI) surveillance was not recommended by 16/18 (88.9%) publishing bodies, although 6/18 (33.3%) specified subgroups for systematic MRI surveillance.
conclusionsAnnual mammography is currently the 'gold standard' for breast imaging surveillance. The role of digital breast tomosynthesis (DBT) remains to be further investigated. Most guidelines do not recommend routine breast ultrasound or MRI surveillance, unless indicated by additional risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.